FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileGenerate Biomedicines, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
Back to Generate Biomedicines, Inc.

Generate Biomedicines, Inc. (GENB) analyst ratings and price targets

The latest rating and price-target changes from Wall Street analysts, newest first — the firm, the analyst, and the article each one was published in.

Average 12-month target $26.00 · Consensus Buy (2 analysts)

Firm · analystDateRatingPrice targetSource
HC Wainwright & Co.Oct 5, 2026MaintainsBuy——
HC Wainwright & Co.Sep 8, 2026MaintainsBuy——
H.C. WainwrightAug 28, 2026MaintainsBuy$30.00from $25.00TheFly ↗
Morgan StanleySean LaamanMay 14, 2026MaintainsOverweight$22.00TheFly ↗
H.C. WainwrightMitchell KapoorMay 8, 2026MaintainsBuy$25.00TheFly ↗

Source: Wall Street analysts' published price targets and ratings, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.